These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24661990)

  • 1. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?
    Hoirisch-Clapauch S; Nardi AE; Gris JC; Brenner B
    Thromb Res; 2014 Jul; 134(1):11-6. PubMed ID: 24661990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?
    Schlienger RG; Meier CR
    Am J Cardiovasc Drugs; 2003; 3(3):149-62. PubMed ID: 14727927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.
    Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC
    Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
    Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
    Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection.
    Maurer-Spurej E
    Cell Mol Life Sci; 2005 Jan; 62(2):159-70. PubMed ID: 15666087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of selective serotonin reuptake inhibitors on human platelet serotonin.
    Maurer-Spurej E; Pittendreigh C; Solomons K
    Thromb Haemost; 2004 Jan; 91(1):119-28. PubMed ID: 14691577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of antidepressants on hemostasis.
    Halperin D; Reber G
    Dialogues Clin Neurosci; 2007; 9(1):47-59. PubMed ID: 17506225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.
    de Abajo FJ
    Drugs Aging; 2011 May; 28(5):345-67. PubMed ID: 21542658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
    Andrade C; Sandarsh S; Chethan KB; Nagesh KS
    J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
    Hallbäck I; Hägg S; Eriksson AC; Whiss PA
    Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.
    Sauer WH; Berlin JA; Kimmel SE
    Circulation; 2003 Jul; 108(1):32-6. PubMed ID: 12821544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter.
    Anderson GM; Bruno-Pacella I
    Psychopharmacology (Berl); 2023 Jan; 240(1):1-13. PubMed ID: 36399187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.
    Wozniak G; Toska A; Saridi M; Mouzas O
    Med Sci Monit; 2011 Sep; 17(9):RA205-14. PubMed ID: 21873959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
    Nair GV; Gurbel PA; O'Connor CM; Gattis WA; Murugesan SR; Serebruany VL
    Am J Cardiol; 1999 Aug; 84(3):321-3, A8. PubMed ID: 10496443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows.
    Valenti TW; Gould GG; Berninger JP; Connors KA; Keele NB; Prosser KN; Brooks BW
    Environ Sci Technol; 2012 Feb; 46(4):2427-35. PubMed ID: 22296170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates.
    Reikvam AG; Hustad S; Reikvam H; Apelseth TO; Nepstad I; Hervig TA
    Platelets; 2012; 23(4):299-308. PubMed ID: 22273511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetine.
    Li R; Qu J; Wu C; Fang Z; Hong X; Xu H
    Eur J Pharmacol; 2020 Sep; 883():173385. PubMed ID: 32710955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.